Bio-receptor Screening and MAO Inhibition

In 1993, I sent a sample of salvinorin-A to Dave Nichols at Purdue University. Dr. Nichols was involved in an NIMH funded research program, which enabled him to have the material exhaustively screened by the commercial bio-receptor screening service, NovaScreen™.

The screening results showed no significant competitive inhibition of reference target compounds at any of the following sites tested. The receptor sites tested included those effected by most other major psychoactive drugs.